Gabor F, Stangl M, Wirth M
Institute of Pharmaceutical Technology, the University of Vienna, Althanstrasse 14, A-1090, Vienna, Austria.
J Control Release. 1998 Nov 13;55(2-3):131-42. doi: 10.1016/s0168-3659(98)00043-1.
In order to take advantage of the biorecognition between lectins and specific carbohydrates for targeted drug delivery, fluorescein-labelled lectins of different carbohydrate specificities were screened for binding to human colorectal carcinoma cell lines by flow cytometry and confocal microscopy. The lectin-binding rate increased as follows: Dolichos biflorus agglutinin, DBA<peanut agglutinin, PNA<Lens culinaris agglutinin, LCA<Solanum tuberosum lectin, STL<Ulex europaeus isoagglutinin I, UEA-I<wheat germ agglutinin, WGA (Caco-2); PNA<UEA-I<WGA (HT-29); DBA<UEA-I<WGA (HCT-8), thus reflecting the glycosylation pattern of the cells. Compared to the BSA-binding capacity of the cells, the extent of nonspecific binding was strongly dependent on the type of cell line and lectin under investigation being lower than 2% in the case of WGA, STL and UEA-I/Caco-2 and HT-29 cells. Whereas 50% of DBA was bound nonspecifically to Caco-2 cells, the interactions DBA/HCT-8 and PNA/HT-29 were due to nonspecific binding. By competitive inhibition of lectin-adhesion to the cells upon addition of the complementary carbohydrate, specificity of lectin-binding was confirmed except for the interaction of DBA/HCT-8 and PNA/HT-29. Following on from this work, we consider WGA-, STL- and UEA-I-mediated drug delivery to be a promising approach for peroral bioadhesive formulations adhering to absorptive enterocytes.
为了利用凝集素与特定碳水化合物之间的生物识别作用实现靶向药物递送,通过流式细胞术和共聚焦显微镜筛选了具有不同碳水化合物特异性的荧光素标记凝集素与人大肠癌细胞系的结合情况。凝集素结合率的增加顺序如下:双花扁豆凝集素(DBA)<花生凝集素(PNA)<兵豆凝集素(LCA)<马铃薯凝集素(STL)<荆豆凝集素I(UEA-I)<麦胚凝集素(WGA)(Caco-2细胞);PNA<UEA-I<WGA(HT-29细胞);DBA<UEA-I<WGA(HCT-8细胞),从而反映了细胞的糖基化模式。与细胞的牛血清白蛋白(BSA)结合能力相比,非特异性结合程度强烈依赖于所研究的细胞系和凝集素类型,在WGA、STL和UEA-I与Caco-2和HT-29细胞的情况下,非特异性结合低于2%。虽然50%的DBA与Caco-2细胞非特异性结合,但DBA/HCT-8和PNA/HT-29之间的相互作用是由于非特异性结合。通过添加互补碳水化合物竞争性抑制凝集素与细胞的粘附,除了DBA/HCT-8和PNA/HT-29的相互作用外,证实了凝集素结合的特异性。基于这项工作,我们认为WGA、STL和UEA-I介导的药物递送是一种用于粘附在吸收性肠细胞上的口服生物粘附制剂的有前景的方法。